JOHNSON & JOHNSON |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.56 CAD | +0.15% |
|
-1.95% | -7.52% |
| 06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
| 06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
f7268a07252326f26c.8Rqu7edwNR2b0RqapO6wk-qPPmYGWy_yoJF5TyarGT0.hG7NgbQhRm31n3jg9p3l-Nq-WS9OKxinysk_GBfue0WzaOnY3zFhLvSdXw~7eb5d10354461c190c73cb73df789119
